Achillion Reports First Quarter 2014 Financial Results

Go back to Achillion Reports First Quarter 2014 Financial Results

Achillion Pharmaceuticals, Inc. (ACHN) Posts Q1 Loss of 17c/Share

May 7, 2014 6:06 AM EDT

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.

... More